Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botticelli: Nebivolol and Amlodipine in Hypertension
NCT05513937Phase 4Completed
- Sponsor
- Menarini Group
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nebivolol and amlodipine in hypertension (HTN) (2 arms), sponsored by Menarini Group. Primary endpoint: Change in Mean Sitting Diastolic Blood Pressure at 8 weeks. Started May 2022; status: completed.
02
Drugs
nebivololamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05513937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05513937.